TipRanks
Oscar Health (OSCR)
NYSE:OSCR
US Market
Want to see OSCR full AI Analyst Report?

Oscar Health (OSCR) Ratios

2,644 Followers

Oscar Health Ratios

OSCR's free cash flow for Q2 2026 was $1.00. For the 2026 fiscal year, OSCR's free cash flow was decreased by $ and operating cash flow was $0.08. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.08 0.95 0.90 0.00 1.26
Quick Ratio
1.08 0.95 0.90 0.00 1.26
Cash Ratio
0.47 0.57 0.48 0.00 0.48
Solvency Ratio
0.06 -0.08 0.02 -0.09 -0.16
Operating Cash Flow Ratio
0.50 0.23 0.31 0.00 0.12
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 201.59M$ -731.27M$ -978.90M$ -2.80B$ 487.35M
Leverage Ratios
Debt-to-Assets Ratio
0.04 0.07 0.06 0.08 0.07
Debt-to-Equity Ratio
0.21 0.44 0.30 0.37 0.33
Debt-to-Capital Ratio
0.17 0.31 0.23 0.27 0.25
Long-Term Debt-to-Capital Ratio
0.17 0.31 0.23 0.27 0.25
Financial Leverage Ratio
5.47 6.47 4.78 4.48 5.08
Debt Service Coverage Ratio
37.53 -22.54 3.45 -8.75 -25.27
Interest Coverage Ratio
39.37 -22.52 2.41 -10.86 -26.97
Debt to Market Cap
0.06 0.11 0.09 0.15 0.57
Interest Debt Per Share
1.48 1.71 1.34 1.46 1.51
Net Debt to EBITDA
-5.75 5.99 -13.75 7.41 2.20
Profitability Margins
Gross Profit Margin
44.93%14.38%20.10%100.00%100.00%
EBIT Margin
3.95%-3.59%0.62%-4.14%-14.24%
EBITDA Margin
4.14%-3.34%0.97%-3.62%-13.87%
Operating Profit Margin
4.07%-3.39%0.62%-4.56%-14.79%
Pretax Profit Margin
3.85%-3.74%0.36%-4.56%-14.79%
Net Profit Margin
3.60%-3.79%0.28%-4.62%-14.70%
Continuous Operations Profit Margin
3.60%-3.79%0.28%-4.62%-14.77%
Net Income Per EBT
93.38%101.34%76.08%101.28%99.38%
EBT Per EBIT
94.51%110.33%58.37%100.00%100.00%
Return on Assets (ROA)
4.91%-7.01%0.53%-7.52%-13.39%
Return on Equity (ROE)
38.53%-45.33%2.51%-33.67%-68.09%
Return on Capital Employed (ROCE)
24.60%-27.10%3.43%-7.42%-48.32%
Return on Invested Capital (ROIC)
22.98%-27.10%2.68%0.00%-48.27%
Return on Tangible Assets
4.91%-7.01%0.53%-7.52%-13.39%
Earnings Yield
6.09%-11.75%0.79%-13.35%-115.99%
Efficiency Ratios
Receivables Turnover
40.31 26.44 29.05 11.86 82.74
Payables Turnover
-42.92 -100.44 5.24 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
150.93 132.44 137.40 94.67 68.89
Asset Turnover
1.36 1.85 1.90 1.63 0.91
Working Capital Turnover Ratio
23.20 -40.65 9.56 13.67 9.62
Cash Conversion Cycle
17.56 17.44 -57.03 30.78 4.41
Days of Sales Outstanding
9.06 13.81 12.56 30.78 4.41
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
-8.50 -3.63 69.59 0.00 0.00
Operating Cycle
9.06 13.81 12.56 30.78 4.41
Cash Flow Ratios
Operating Cash Flow Per Share
14.47 4.17 4.07 -1.23 1.79
Free Cash Flow Per Share
14.34 4.03 3.95 -1.34 1.65
CapEx Per Share
0.13 0.14 0.12 0.12 0.14
Free Cash Flow to Operating Cash Flow
0.99 0.97 0.97 1.09 0.92
Dividend Paid and CapEx Coverage Ratio
113.23 30.10 35.06 -10.64 13.11
Capital Expenditure Coverage Ratio
113.23 30.10 35.06 -10.64 13.11
Operating Cash Flow Coverage Ratio
10.13 2.55 3.27 -0.91 1.28
Operating Cash Flow to Sales Ratio
0.29 0.09 0.11 -0.05 0.09
Free Cash Flow Yield
55.92%28.07%29.41%-14.68%67.22%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
17.46 -8.50 122.18 -7.49 -0.86
Price-to-Sales (P/S) Ratio
0.51 0.32 0.35 0.35 0.13
Price-to-Book (P/B) Ratio
4.40 3.86 3.19 2.52 0.59
Price-to-Free Cash Flow (P/FCF) Ratio
1.79 3.56 3.40 -6.81 1.49
Price-to-Operating Cash Flow Ratio
2.06 3.44 3.30 -7.45 1.37
Price-to-Earnings Growth (PEG) Ratio
0.18 <0.01 -1.12 0.13 0.09
Price-to-Fair Value
4.40 3.86 3.19 2.52 0.59
Enterprise Value Multiple
6.47 -3.65 22.43 -2.15 1.29
Enterprise Value
4.11B 1.43B 2.00B 456.61M -737.91M
EV to EBITDA
6.48 -3.65 22.43 -2.15 1.29
EV to Sales
0.27 0.12 0.22 0.08 -0.18
EV to Free Cash Flow
0.95 1.35 2.11 -1.53 -2.10
EV to Operating Cash Flow
0.94 1.30 2.05 -1.68 -1.94
Tangible Book Value Per Share
6.80 3.74 4.23 3.64 4.20
Shareholders’ Equity Per Share
6.79 3.73 4.22 3.63 4.19
Tax and Other Ratios
Effective Tax Rate
0.07 -0.01 0.22 -0.01 <0.01
Revenue Per Share
50.69 44.60 38.18 26.45 19.42
Net Income Per Share
1.82 -1.69 0.11 -1.22 -2.85
Tax Burden
0.93 1.01 0.76 1.01 0.99
Interest Burden
0.97 1.04 0.58 1.10 1.04
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.08 0.18 0.00 0.24 0.34
Stock-Based Compensation to Revenue
<0.01 <0.01 0.01 0.03 0.03
Income Quality
7.94 -2.47 37.45 1.01 -0.62
Currency in USD